Lawrenceville, NJ, United States of America

Rex A Parker



 

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 280(Granted Patents)


Location History:

  • Branford, CT (US) (1993 - 1994)
  • Lawrenceville, NJ (US) (1996)
  • Titusville, NJ (US) (2006 - 2024)

Company Filing History:


Years Active: 1993-2024

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: **Rex A Parker: Innovator in Protein Therapeutics**

Introduction

Rex A Parker is a distinguished inventor based in Lawrenceville, NJ, who has made significant contributions to the field of protein therapeutics. With an impressive portfolio of 17 patents, he is recognized for his pioneering work in developing innovative proteins aimed at treating various cholesterol-related diseases.

Latest Patents

Among Rex A Parker's latest patents is the invention of fibronectin-based scaffold domain proteins that bind PCSK9. This groundbreaking invention addresses critical health issues by providing therapeutic applications for conditions like atherosclerosis and hypercholesterolemia. Furthermore, it encompasses cells that incorporate these proteins, polynucleotides that encode them, and vectors containing the relevant polynucleotides. Another notable patent involves serum albumin-binding fibronectin type III domains. This invention focuses on polypeptides that include the tenth fibronectin type III domains (Fn3) with unique substitutions, enabling them to bind to serum albumin. Additionally, it details fusion molecules that consist of a serum albumin-binding Fn3 joined to a heterologous protein, intended for diagnostic and therapeutic uses.

Career Highlights

Rex A Parker's professional journey includes notable affiliations with Bristol-Myers Squibb Company and Harvard College. His work in these prestigious organizations has allowed him to refine his expertise and focus on innovations that drive advancements in therapeutic strategies.

Collaborations

Throughout his career, Rex has collaborated with talented individuals such as Bowman Miao and Ray Camphausen. These partnerships have further enriched the development and impact of his inventions, fostering an environment of innovation and collaborative problem-solving.

Conclusion

Rex A Parker stands out as a prominent figure in the realm of protein therapeutics, with a strong patent portfolio that underscores his commitment to addressing significant health challenges. His contributions not only enhance the scientific community but also pave the way for innovative solutions that can positively affect the lives of many individuals suffering from cholesterol-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…